Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas
Clinical trial NCT01828008 · UNKNOWN
Trial details
- NCT number
- NCT01828008
- Sponsor
- Han weidong
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.